CURE vs. TYD
CURE (Direxion Daily Healthcare Bull 3x Shares) and TYD (Direxion Daily 7-10 Year Treasury Bull 3X) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while TYD is a Leveraged Bonds fund tracking the NYSE 7-10 Year Treasury Bond Index. Both are passively managed. Over the past 10 years, CURE returned 13.07%/yr vs -5.55%/yr for TYD. At a correlation of -0.08, they often move in opposite directions. CURE charges 1.08%/yr vs 1.09%/yr for TYD.
Performance
CURE vs. TYD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a 3.02% return, which is significantly higher than TYD's -8.67% return. Over the past 10 years, CURE has outperformed TYD with an annualized return of 13.07%, while TYD has yielded a comparatively lower -5.55% annualized return.
CURE
- 1D
- 1.84%
- 1M
- 22.58%
- 6M
- 2.43%
- YTD
- 3.02%
- 1Y
- 60.79%
- 3Y*
- 3.52%
- 5Y*
- 1.07%
- 10Y*
- 13.07%
- ALL TIME*
- 23.98%
TYD
- 1D
- -0.78%
- 1M
- -3.38%
- 6M
- -6.39%
- YTD
- -8.67%
- 1Y
- -3.97%
- 3Y*
- -4.77%
- 5Y*
- -14.54%
- 10Y*
- -5.55%
- ALL TIME*
- 0.96%
CURE vs. TYD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 3.02% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
TYD Direxion Daily 7-10 Year Treasury Bull 3X | -8.67% | 11.68% | -13.89% | -2.87% | -43.32% | -11.36% | 27.62% | 17.88% | 0.76% | 5.64% |
Correlation
The correlation between CURE and TYD is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.08 |
The correlation between CURE and TYD shifts across timeframes, from -0.08 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. TYD — Risk / Return Rank
CURE
TYD
CURE vs. TYD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily 7-10 Year Treasury Bull 3X (TYD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | TYD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.60 | ||
| Sortino ratioReturn per unit of downside risk | +2.37 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.96 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 1.96 | -0.29 | +2.26 |
| Martin ratioReturn relative to average drawdown | 4.37 | -0.64 | +5.00 |
Loading charts...
Drawdowns
CURE vs. TYD - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than TYD's maximum drawdown of -64.28%. Use the drawdown chart below to compare losses from any high point for CURE and TYD.
Loading charts...
Drawdown Indicators
| CURE | TYD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -64.28% | -4.91% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -13.54% | -17.56% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -22.32% | -29.61% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -59.84% | +7.61% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -64.28% | -4.91% |
Current DrawdownCurrent decline from peak | -18.23% | -60.31% | +42.08% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -22.22% | +4.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.97% | 6.24% | +7.73% |
Volatility
CURE vs. TYD - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 18.16% compared to Direxion Daily 7-10 Year Treasury Bull 3X (TYD) at 3.93%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than TYD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | TYD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.16% | 3.93% | +14.23% |
Volatility (6M)Calculated over the trailing 6-month period | 34.67% | 10.30% | +24.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.66% | 13.80% | +32.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.53% | 22.92% | +21.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.77% | 20.20% | +29.57% |
CURE vs. TYD - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is lower than TYD's 1.09% expense ratio.
Dividends
CURE vs. TYD - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.10%, less than TYD's 3.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.10% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
TYD Direxion Daily 7-10 Year Treasury Bull 3X | 3.38% | 2.97% | 3.10% | 2.71% | 0.55% | 0.00% | 9.80% | 0.92% | 1.10% | 0.01% | 6.84% | 1.65% |
Frequently Asked Questions
CURE and TYD have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (18.16%) compared to TYD (3.93%). In terms of maximum drawdown, CURE dropped -69.19% vs TYD's -64.28%.
On 10-year performance, CURE leads with 13.07% vs -5.55% for TYD. On fees, CURE is cheaper at 1.08% per year. On volatility, TYD has been the lower-risk option at 3.93%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.07% return vs -5.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 1.08% expense ratio, compared with 1.09% for TYD.
TYD has the higher dividend yield at 3.38%, compared with 1.10% for CURE.
CURE is categorized as Leveraged Equities, while TYD is Leveraged Bonds. CURE tracks Health Care Select Sector Index (300%), while TYD tracks NYSE 7-10 Year Treasury Bond Index. Their fees differ too: 1.08% for CURE and 1.09% for TYD.
CURE currently has the higher Sharpe Ratio (1.31 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and TYD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer